Skip to main content

Peer Review reports

From: Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis

Original Submission
9 Jul 2021 Submitted Original manuscript
25 Aug 2021 Reviewed Reviewer Report
10 Sep 2021 Reviewed Reviewer Report
13 Sep 2021 Reviewed Reviewer Report
3 Oct 2021 Author responded Author comments - Emily A Kendall
Resubmission - Version 2
3 Oct 2021 Submitted Manuscript version 2
4 Oct 2021 Reviewed Reviewer Report
10 Oct 2021 Reviewed Reviewer Report
5 Nov 2021 Reviewed Reviewer Report
10 Nov 2021 Author responded Author comments - Emily A Kendall
Resubmission - Version 3
10 Nov 2021 Submitted Manuscript version 3
11 Nov 2021 Author responded Author comments - Emily A Kendall
11 Nov 2021 Reviewed Reviewer Report
Resubmission - Version 4
11 Nov 2021 Submitted Manuscript version 4
15 Nov 2021 Author responded Author comments - Emily A Kendall
Resubmission - Version 5
15 Nov 2021 Submitted Manuscript version 5
Publishing
15 Nov 2021 Editorially accepted
14 Dec 2021 Article published 10.1186/s12916-021-02189-w

You can find further information about peer review here.

Back to article page